3-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenol
| Title | Journal |
|---|---|
| Inhibition of human immunodeficiency virus type-1 by cdk inhibitors. | AIDS research and therapy 20100101 |
| Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro. | Pharmaceutical research 20090201 |
| A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. | Proceedings of the National Academy of Sciences of the United States of America 20071218 |
| Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 2. Identification of small-molecule inhibitors via coupling with virtual screening. | Journal of medicinal chemistry 20050505 |
| Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery. | Analytical chemistry 20050301 |
| Frontal affinity chromatography with MS detection of EphB2 tyrosine kinase receptor. 1. Comparison with conventional ELISA. | Journal of medicinal chemistry 20041007 |
| Treatment of post-bone marrow transplant acute graft-versus-host disease with a rationally designed JAK3 inhibitor. | Leukemia & lymphoma 20020701 |
| 4-[3-Bromo-4-hydroxyphenyl)amino]-6,7-dimethoxyquinazolin-1-ium chloride methanol solvate and 4-[(3-hydroxyphenyl)amino]-6,7-dimethoxy-1-quinazolinium chloride. | Acta crystallographica. Section C, Crystal structure communications 20010101 |
| Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. | Journal of medicinal chemistry 19991230 |